Video Shorts

1:29
Long-Term Goal-Based TKI Treatment Decision-Making for Patients With CML
7 months ago
by
Jorge Cortes, MD

1:00
Targeted Therapies Continue to Reshape Third-Line Treatment Sequencing Decisions in CRC
8 months ago
by
Shubham Pant, MD, MBBS

0:30
ASH Guidelines Provide Key Recommendations in AYA ALL Management
8 months ago
by
Wendy Stock, MD

1:29
Local vs Systemic Therapy for CNS Metastases in Lung Cancer
8 months ago
by
Laura Alder, MD

0:39
Previewing Future Directions for Investigating RSK Inhibition in Breast Cancer
8 months ago
by
Hung T. Khong, MD

2:04
Utilizing MRD Status in Acute Lymphoblastic Leukemia Management
8 months ago
by
Jae Park, MD

1:11
Of mice but not men. Problems of the randomized clinical trial
8 months ago
by
Maurie Markman, MD

1:02
Examining Pasritamig Plus Docetaxel in mCRPC
8 months ago
by
David R. Wise, MD, PhD

0:56
Peptide Receptor Radionucleotide Therapies Gain Momentum in NETs
8 months ago
by
Shubham Pant, MD, MBBS

3:48
OncLive News Roundup for the Week of 3/8
8 months ago
by
Chris Ryan(+1 more)

1:25
Ethics and Identity in Oncology: Clinician vs Investigator
8 months ago
by
Maurie Markman, MD

1:29
Recapping Top Coverage from MBCC 2026!
8 months ago
by
Ashling Wahner (+1 more)

1:59
Navigating Treatment Selection After HMA Failure in Higher-Risk MDS
8 months ago
by
Rami S. Komrokji, MD

0:42
Navigating BTK Inhibitor Data for MCL and Important Next Steps for the Field
8 months ago
by
Tycel Phillips, MD

0:37
Spotlighting the Role of Cardio-Oncology in Breast Cancer Care
8 months ago
by
Javid Moslehi, MD

2:16
Unpacking Real-World Outcomes With ARP Inhibitor Therapy in mHSPC
8 months ago
by
Alicia Morgans, MD, MPH, FASCO

1:07
Research Areas of Interest in Frontline Lower-Risk MDS
8 months ago
by
Jan Bewersdorf, MD, FACP

1:50
Inside the Most Notable Data in Prostate Cancer From ASCO GU 2026
8 months ago
by
Neha Vapiwala, MD, FASTRO, FASCO, FACR

1:20
Is Early-Onset CRC a Biologically Distinct Disease? Drs Marshall and Lieu Explore the Evidence
8 months ago
by
Courtney Flaherty

0:26
Previewing Integrative Medicine Conversations in Breast Cancer
8 months ago
by
Lillian Rodich, MSPAS, MPH

0:57
Asking Breast Cancer Experts About the Most Inspirational Women in Their Life!
8 months ago
by
Ashling Wahner (+1 more)

0:44
Previewing the Breast Cancer Briefing Podcast Series
8 months ago
by
Sara Nunnery, MD, MSCI(+1 more)

0:37
Asking Experts Their Favorite Thing to do in Miami While at MBCC!
8 months ago
by
Ashling Wahner (+1 more)

1:45
Highlights of the 2026 Women in Oncology Event
8 months ago
by
Ashling Wahner

0:37
A Day in the Life of OncLive at MBCC!
8 months ago
by
Ashling Wahner (+1 more)

0:53
Examining Caregiver Support in Prostate Cancer
8 months ago
by
Daniel J. George, MD

1:00
Why Meetings Like the Miami Breast Cancer Conference Matter
8 months ago
by
Hope S. Rugo, MD, FASCO

1:06
Outcomes for Orca-T Plus Allogeneic CAR T-Cell Therapy in B-ALL
8 months ago
by
Alfonso Molina, MD, MPH

0:44
Unpacking the KEYNOTE-B15 Data
8 months ago
by
Matthew D. Galsky, MD

1:15
Navigating the Complexity of Acute Lymphoblastic Leukemia Management
8 months ago
by
Daniel J. DeAngelo, MD, PhD
Advertisement
Advertisement
Trending on OncLive
1
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ESMO 2026
2
TP53 Comutations, Long-Term Toxicity, and Sunvozertinib Access Shape EGFR+ NSCLC Treatment Decisions
3
Phase 1 Study of BGB-B2033 (GPC3 x 4-1BB Bispecific Antibody) Monotherapy: First Disclosure of Dose Optimization and Dose Escalation Update in Advanced Hepatocellular Carcinoma
4
Outpatient Models and Prophylactic Measures Help Bring Bispecifics Into Community Practice for R/R Myeloma
5
